Yoshida, K., Chan, P., Marchand, M., Zhang, R., Wu, B., Ballinger, M., & Sternheim, N. (2022). Tumor Growth Inhibition-Overall Survival Subgroup Analysis of Atezolizumab in the IMpower150 Study. The AAPS journal, 24(3), . https://doi.org/10.1208/s12248-022-00710-4
Chicago Style (17th ed.) CitationYoshida, Kenta, Phyllis Chan, Mathilde Marchand, Rong Zhang, Benjamin Wu, Marcus Ballinger, and Nitzan Sternheim. "Tumor Growth Inhibition-Overall Survival Subgroup Analysis of Atezolizumab in the IMpower150 Study." The AAPS Journal 24, no. 3 (2022). https://doi.org/10.1208/s12248-022-00710-4.
MLA (9th ed.) CitationYoshida, Kenta, et al. "Tumor Growth Inhibition-Overall Survival Subgroup Analysis of Atezolizumab in the IMpower150 Study." The AAPS Journal, vol. 24, no. 3, 2022, https://doi.org/10.1208/s12248-022-00710-4.